NCT01412710View on ClinicalTrials.gov

Vitamin D Supplementation on Cardiovascular Risk Factors

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Type 2 Diabetes
Interventions
DRUG

Cholecalciferol

4000 IU or 6000 IU given vitamin D3 once daily, orally for 6 months.

Trial Locations (1)

33199

Human Nutrition Laboratory, Florida International University, Miami

All Listed Sponsors
lead

Florida International University

OTHER

NCT01412710 - Vitamin D Supplementation on Cardiovascular Risk Factors | Biotech Hunter | Biotech Hunter